• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Exelixis

Exelixis

Exelixis Inc EXEL 3 Star

Last Price$1.76Day Change (%)2.33%
Open Price$1.70Day Change ($)0.04
Day Range1.68–1.7652-Week Range1.35–8.41

As of Wed 11/26/2014 04:51 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib

    Exelixis Announces Positive Preliminary Data From an Investigator-Sponsored Phase 1 Trial of XL888 and Vemurafenib

  2. Research and Markets: Global Papillary Thyroid Cancer therapeutics Pipeline Report H2 2014 - Analysis of 6 Companies & 8 Drug Profiles

    Research and Markets: Global Papillary Thyroid Cancer therapeutics Pipeline Report H2 2014 - Analysis of 6 Companies & 8 Drug Profiles

  3. Research and Markets: Global Retail Logistics Market 2014-2018: Key Vendors Are FedEx, Kuehne + Nagel, Schneider and United Parcel Service

    Research and Markets: Global Retail Logistics Market 2014-2018: Key Vendors Are FedEx, Kuehne + Nagel, Schneider and United Parcel Service

  4. Is This the Year Exelixis Excels?

    The lack of early success in its lead drug's cancer trial scares the market, but we see a buying opportunity.

  5. Beware 5-Star Stocks Bearing No Moats

    Lack of competitive advantages may mean these companies aren't the bargains they seem to be.

  6. Don't Bail on Biotech

    We see opportunity as fleeing investors trigger an irrational sell-off.

  7. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  8. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.